- Citations, last 5 years
- 40
- Works, last 5 years
- 8
- h-index
- 11
- Scientists listed
- 1
- Grants since 2016
- 1
Grants received
2019–2020 · commercial · H2020 - SME-1
A feasibility study on the development of Psorax35 as the first and only oral treatment for mild-to-moderate psoriasis with positive effects on co-morbidities.
Arctic Nutrition (Norway) · funded by European Commission
